Febe Brackx
Biographic Data
| ID | 10466090 |
|---|---|
| NAME | Febe Brackx |
| GIVEN NAMES | Febe |
| FAMILY NAME | Brackx |
| SIGNATURE | BRACKX F |
| AFFILIATIONS | KU Leuven |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Estimating the minimal clinically important difference for the Myasthenia Gravis Quality of Life revised scale (MG-QOL15R)
To estimate the minimal clinically important difference (MCID) for the MG-QOL15R. Data from two multi-country myasthenia gravis studies were used: the ADAPT RCT (n = 157) and the MyRealWorld-MG (MRW-MG) survey (n = 92). MCIDs were estimated using four anchor-based methods: change difference (CD), receiver operating characteristic (ROC) curve with Area Under the Curve (AUC), linear regression, and equipercentile linking. MG-Activities of Daily Liv…
The Effect of Transborder Mobility on Covid-19 Incidences in Belgium
Belgium is a geographically small country bordered by The Netherlands, France, Germany, and Luxembourg, with intense transborder mobility, defined as mobility in the border regions with neighboring countries. It is therefore of interest to examine how the 14-day COVID-19 confirmed case incidence in the border regions is influenced by that of the adjacent regions in the neighboring countries and thus, whether and how it differs from that in the ad…
No prominent works on this page.
The Effect of Transborder Mobility on Covid-19 Incidences in Belgium
Belgium is a geographically small country bordered by The Netherlands, France, Germany, and Luxembourg, with intense transborder mobility, defined as mobility in the border regions with neighboring countries. It is therefore of interest to examine how the 14-day COVID-19 confirmed case incidence in the border regions is influenced by that of the adjacent regions in the neighboring countries and thus, whether and how it differs from that in the ad…
Estimating the minimal clinically important difference for the Myasthenia Gravis Quality of Life revised scale (MG-QOL15R)
To estimate the minimal clinically important difference (MCID) for the MG-QOL15R. Data from two multi-country myasthenia gravis studies were used: the ADAPT RCT (n = 157) and the MyRealWorld-MG (MRW-MG) survey (n = 92). MCIDs were estimated using four anchor-based methods: change difference (CD), receiver operating characteristic (ROC) curve with Area Under the Curve (AUC), linear regression, and equipercentile linking. MG-Activities of Daily Liv…
Adrenal Hormones and Disorders (1 work) · Capital city (1 work) · Capital region (1 work) · Confidence interval (1 work) · Coronavirus disease 2019 (COVID-19 (1 work) · COVID-19 Digital Contact Tracing (1 work) · COVID-19 epidemiological studies (1 work) · Demographic economics (1 work) · Demography (1 work) · Demography (1 work)